Nicotinamide structure
|
Common Name | Nicotinamide | ||
---|---|---|---|---|
CAS Number | 98-92-0 | Molecular Weight | 122.125 | |
Density | 1.2±0.1 g/cm3 | Boiling Point | 257.7±32.0 °C at 760 mmHg | |
Molecular Formula | C6H6N2O | Melting Point | 128-131 °C(lit.) | |
MSDS | Chinese USA | Flash Point | 109.7±25.1 °C | |
Symbol |
GHS07 |
Signal Word | Warning |
Use of NicotinamideNicotinamide is a form of vitamin B3 that plays essential roles in cell physiology through facilitating NAD+ redox homeostasis and providing NAD+ as a substrate to a class of enzymes that catalyze non-redox reactions. Nicotinamide is an inhibitor of SIRT1. |
Name | 3-Pyridinecarboxamide |
---|---|
Synonym | More Synonyms |
Description | Nicotinamide is a form of vitamin B3 that plays essential roles in cell physiology through facilitating NAD+ redox homeostasis and providing NAD+ as a substrate to a class of enzymes that catalyze non-redox reactions. Nicotinamide is an inhibitor of SIRT1. |
---|---|
Related Catalog | |
Target |
PARP-1 Human Endogenous Metabolite |
In Vitro | Pretreatment with the poly (ADP-ribose) polymerase (PARP) inhibitor nicotinamide is able to prevent HCN2 cell death. When nicotinamide is added prior to t-BuOOH, it is able to prevent neuronal cell death and inhibit apoptosis. Nicotinamide-pretreated neurons have higher expression levels of inhibitors of apoptosis (IAP) genes[1]. Nicotinamide inhibits vasoconstriction by ET. Nicotinamide also alleviates oxidative stress, which exacerbates PE and FGR[3]. |
In Vivo | Normal and streptozotocin-nicotinamide induced adult male diabetic rats receive quercetin (10, 25 and 50 mg/kg/bw) orally, and cause significant decrease in FBG and cardiac injury marker levels with increased in insulin levels[2]. Nicotinamide improves maternal hypertension, proteinuria, and glomerular endotheliosis in RUPP mice. Moreover, nicotinamide prolongs pregnancies, and improves survival and growth of the embryos in RUPP PE mice[3]. |
Animal Admin | DM is induced via a single intraperitoneal (i.p) injection of nicotinamide (110 mg/kg/body weight) dissolved in normal saline 15 min prior to streptozotocin (STZ) (55 mg/kg/body weight) injection, which is dissolved in a freshly prepared 0.1mol/Lcitrate buffer (pH 4.5). These injections are given following an overnight fast. Control rats (n=6) are injected with the same amount of solvent. In order to prevent hypoglycemia in the first 24 h following STZ injection, rats are allowed to have free access to water with 5% dextrose (D5W). Three days after STZ-nicotinamide injection, rats with FBG levels greater than 7.0 mM are considered as diabetic. |
References |
Density | 1.2±0.1 g/cm3 |
---|---|
Boiling Point | 257.7±32.0 °C at 760 mmHg |
Melting Point | 128-131 °C(lit.) |
Molecular Formula | C6H6N2O |
Molecular Weight | 122.125 |
Flash Point | 109.7±25.1 °C |
Exact Mass | 122.048012 |
PSA | 55.98000 |
LogP | -0.24 |
Appearance of Characters | powder | white |
Vapour Pressure | 0.0±0.6 mmHg at 25°C |
Index of Refraction | 1.590 |
Storage condition | 0-6°C |
Stability | Stable. Incompatible with strong oxidizing agents. |
Water Solubility | 1000 g/L (20 ºC) |
CHEMICAL IDENTIFICATION
HEALTH HAZARD DATAACUTE TOXICITY DATA
MUTATION DATA
|
Symbol |
GHS07 |
---|---|
Signal Word | Warning |
Hazard Statements | H315-H319-H335 |
Precautionary Statements | P261-P305 + P351 + P338 |
Personal Protective Equipment | dust mask type N95 (US);Eyeshields;Gloves |
Hazard Codes | Xi |
Risk Phrases | R36/37/38 |
Safety Phrases | S26;S36 |
RIDADR | NONH for all modes of transport |
WGK Germany | 1 |
RTECS | QS3675000 |
HS Code | 2933399090 |
HS Code | 2933399090 |
---|---|
Summary | 2933399090. other compounds containing an unfused pyridine ring (whether or not hydrogenated) in the structure. VAT:17.0%. Tax rebate rate:13.0%. . MFN tariff:6.5%. General tariff:20.0% |
Epigenetic reprogramming of the type III interferon response potentiates antiviral activity and suppresses tumor growth.
PLoS Biol. 12(1) , e1001758, (2014) Type III interferon (IFN-λ) exhibits potent antiviral activity similar to IFN-α/β, but in contrast to the ubiquitous expression of the IFN-α/β receptor, the IFN-λ receptor is restricted to cells of ep... |
|
Alisertib, an Aurora kinase A inhibitor, induces apoptosis and autophagy but inhibits epithelial to mesenchymal transition in human epithelial ovarian cancer cells.
Drug Des. Devel. Ther. 9 , 425-64, (2015) Ovarian cancer is a leading killer of women, and no cure for advanced ovarian cancer is available. Alisertib (ALS), a selective Aurora kinase A (AURKA) inhibitor, has shown potent anticancer effects, ... |
|
Functionalized tetrahydro-1H-pyrido[4,3-b]indoles: a novel chemotype with Sirtuin 2 inhibitory activity.
Eur. J. Med. Chem. 92 , 145-55, (2015) Sirtuins are protein deacylases with regulatory roles in metabolism and stress response. Functionalized tetrahydro-1H-pyrido[4,3-b]indoles were identified as preferential sirtuin 2 inhibitors, with in... |
Niacinamide |
MFCD00006395 |
Nicotinic acid amide |
Vitamin- B3 |
Witamina PP |
3-Pyridinecarboxamide |
Nicotinamide |
Pyridine-3-carboxamide |
T6NJ CVZ |
Dipigyl |
EINECS 202-713-4 |
Vi-noctyl |